Reata Pharmaceuticals
Reata Pharmaceuticals, Inc. is a pharmaceutical company based in Plano, Texas. Founded in 2002, Reata is primarily focused on investigating experimental oral antioxidative and anti-inflammatory drugs, which dually activate the antioxidative transcription factor Nrf2 and inhibit the pro-inflammatory transcription factor NF-κB.
Wikipage disambiguates
Link from a Wikipage to another Wikipage
primaryTopic
Reata Pharmaceuticals
Reata Pharmaceuticals, Inc. is a pharmaceutical company based in Plano, Texas. Founded in 2002, Reata is primarily focused on investigating experimental oral antioxidative and anti-inflammatory drugs, which dually activate the antioxidative transcription factor Nrf2 and inhibit the pro-inflammatory transcription factor NF-κB.
has abstract
Reata Pharmaceuticals, Inc. is ...... ry transcription factor NF-κB.
@en
revenue ($)
Link from a Wikipage to an external page
Wikipage page ID
29,274,197
page length (characters) of wiki page
Wikipage revision ID
1,022,141,045
Link from a Wikipage to another Wikipage
bloomberg
RETA:US
@en
RETA
@en
name
Reata Pharmaceuticals
@en
reuters
RETA.O
@en
revenue
US $26.52 million
@en
US $53.59 million
@en
sec cik
RETA
@en
symbol
RETA
@en
traded as
NASDAQ:RETA
@en
wikiPageUsesTemplate
yahoo
RETA
@en
subject
comment
Reata Pharmaceuticals, Inc. is ...... ry transcription factor NF-κB.
@en
label
Reata Pharmaceuticals
@en